Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (6)

2023

  1. Adjuvant dabrafenib and trametinib for patients with resected BRAF -mutated melanoma: DESCRIBE-AD real-world retrospective observational study

    Melanoma research, Vol. 33, Núm. 5, pp. 388-397

2022

  1. Follow-up of primary melanoma patients with high risk of recurrence: recommendations based on evidence and consensus

    Clinical and Translational Oncology, Vol. 24, Núm. 8, pp. 1515-1523

2013

  1. Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

    Clinical and Translational Oncology, Vol. 15, Núm. 6, pp. 425-433

  2. Erratum: Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor (Clinical and Translational Oncology DOI: 10.1007/s12094-012-0985-x)

    Clinical and Translational Oncology

2010

  1. Renal cell carcinoma: Complete pathological response in a patient with gastric metastasis of renal cell carcinoma

    Anti-Cancer Drugs, Vol. 21, Núm. SUPPL.1

2007

  1. Choroid plexus carcinoma: A rare condition and its therapeutic management

    Clinical and Translational Oncology, Vol. 9, Núm. 6, pp. 401-403